Rajni Agarwal-Hashmi

Publications

• High-dose chemotherapy followed by stem cell rescue for high-risk germ cell tumors: the Stanford experience. Agarwal R, Dvorak CC, Stockerl-Goldstein KE, Johnston L, Srinivas S. Bone Marrow Transplant. 2009; 43 (7): 547-52
• Nontuberculous mycobacteria infections in immunocompromised patients: single institution experience. Wei MC, Banaei N, Yakrus MA, Stoll T, Gutierrez KM, Agarwal R. J Pediatr Hematol Oncol. 2009; 31 (8): 556-60
• Pathological evidence of Wolman's disease following hematopoietic stem cell transplantation despite correction of lysosomal acid lipase activity. Gramatges MM, Dvorak CC, Regula DP, Enns GM, Weinberg K, Agarwal R. Bone Marrow Transplant. 2009; 44 (7): 449-50
• Hematopoietic stem cell transplant for pediatric acute promyelocytic leukemia. Dvorak CC, Agarwal R, Dahl GV, Gregory JJ, Feusner JH. Biol Blood Marrow Transplant. 2008; 14 (7): 824-30
• Safety of hematopoietic stem cell transplantation in children less than three years of age. Dvorak CC, Wright NB, Wong WB, Kristovich KM, Matthews EW, Weinberg KI, Amylon MD, Agarwal R. Pediatr Hematol Oncol. 2008; 25 (8): 705-22
• Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. Deeg HJ, O'Donnell M, Tolar J, Agarwal R, Harris RE, Feig SA, Territo MC, Collins RH, McSweeney PA, Copelan EA, Khan SP, Woolfrey A, Storer B. Blood. 2006; 108 (5): 1485-91
• Use of intravenous mycophenolate mofetil for graft-versus-host disease prophylaxis in an allogeneic hematopoietic stem cell transplant recipient with an allergic reaction to cyclosporine and tacrolimus. Dvorak CC, Callard E, Agarwal R. Bone Marrow Transplant. 2006; 38 (3): 253-4
• Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation. Dvorak CC, Steinbach WJ, Brown JM, Agarwal R. Bone Marrow Transplant. 2005; 36 (7): 621-9
• High-dose therapy and autologous hematopoietic stem-cell transplantation for recurrent or refractory pediatric Hodgkin's disease: results and prognostic indices. Lieskovsky YE, Donaldson SS, Torres MA, Wong RM, Amylon MD, Link MP, Agarwal R. J Clin Oncol. 2004; 22 (22): 4532-40
• Continuous veno-venous hemofiltration may improve survival from acute respiratory distress syndrome after bone marrow transplantation or chemotherapy. DiCarlo JV, Alexander SR, Agarwal R, Schiffman JD. J Pediatr Hematol Oncol. 2003; 25 (10): 801-5
• Antithrombin-III for the treatment of chemotherapy-induced organ dysfunction following bone marrow transplantation. Morris JD, Harris RE, Hashmi R, Sambrano JE, Gruppo RA, Becker AT, Morris CL. Bone Marrow Transplant. 1997; 20 (10): 871-8
• Retroviral transduction of CD34-enriched hematopoietic progenitor cells under serum-free conditions. Sekhar M, Kotani H, Doren S, Agarwal R, McGarrity G, Dunbar CE. Hum Gene Ther. 1996; 7 (1): 33-8
• Long-term culture of chronic myelogenous leukemia marrow cells on stem cell factor-deficient stroma favors benign progenitors. Agarwal R, Doren S, Hicks B, Dunbar CE. Blood. 1995; 85 (5): 1306-12
• Splenic and hepatic peliosis: MR findings. Maves CK, Caron KH, Bisset GS, Agarwal R. AJR Am J Roentgenol. 1992; 158 (1): 75-6